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PThe Impact of For-Profit Hospital Status
on the Care and Outcomes of Patients With
Non–ST-Segment Elevation Myocardial Infarction
Results From the CRUSADE Initiative
Bimal R. Shah, MD,* Seth W. Glickman, MD, MBA,* Li Liang, PHD,* W. Brian Gibler, MD,†
E. Magnus Ohman, MD,* Charles V. Pollack, JR, MD, MA,‡ Matthew T. Roe, MD, MHS,*
Eric D. Peterson, MD, MPH*
Durham, North Carolina; Cincinnati, Ohio; and Philadelphia, Pennsylvania
Objectives We sought to determine whether for-profit status influenced hospitals’ care or outcomes among non–ST-
segment elevation myocardial infarction (NSTEMI) patients.
Background While for-profit hospitals potentially have financial incentives to selectively care for younger, healthier patients,
perform highly reimbursed procedures, reduce costs by limiting access to expensive medications, and encourage
shorter in-patient length of stay, there are limited data available to investigate these issues objectively.
Methods Using data from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse out-
comes with Early implementation of the American College of Cardiology/American Heart Association guidelines)
Initiative, we investigated whether for-profit status influenced hospitals’ patient case mix, care, or outcomes
among 145,357 patients with NSTEMI treated between January 1, 2001, and December 31, 2005, at 532 U.S.
hospitals. Impact of for-profit status on care and outcomes was analyzed overall and after adjustment for clinical
and facility factors using regression modeling.
Results Patients (n  11,658) treated at 58 for-profit hospitals were of similar age and gender, but were more likely to
be nonwhite (black, Asian, Hispanic, and other) and have health maintenance organization/private insurance,
diabetes mellitus, congestive heart failure, hypertension, and renal insufficiency compared with 133,699 pa-
tients treated at 474 nonprofit hospitals. For-profit hospitals were less likely to use discharge beta-blockers, but
all other treatments were similar including the use of interventional procedures (cardiac catheterization and re-
vascularization procedures) compared with nonprofit centers. In-hospital length of stay and mortality were also
similar by hospital type.
Conclusions We found no evidence that for-profit hospitals selectively treat less sick patients, provide less evidence-based
care, limit in-hospital stays, or have patients with worse acute outcomes than nonprofit centers. (J Am Coll
Cardiol 2007;50:1462–8) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.07.012a
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fospitals in the U.S. can be broadly defined by their
nancial status as being for-profit or nonprofit, with the
atter receiving tax-preferred status from the federal govern-
ent for providing uncompensated care to the uninsured
rom the *Duke Clinical Research Institute, Duke University Medical Center,
urham, North Carolina; †University of Cincinnati College of Medicine, Cincinnati,
hio; and ‡Pennsylvania Hospital, Philadelphia, Pennsylvania. The CRUSADE
nitiative is a National Quality Improvement Initiative of the Duke Clinical Research
nstitute and is funded by the Schering-Plough Corporation. The Bristol-Myers
quibb/Sanofi Pharmaceuticals Partnership provides additional funding support.
illennium Pharmaceuticals, Inc. also provided funding for this research. See
ccompanying online Cardiosource Slide Set.C
Manuscript received February 5, 2007; revised manuscript received June 21, 2007,
ccepted July 9, 2007.nd underinsured (1). For-profit hospitals are subject to
ncreased public scrutiny given concern that they may
referentially select healthier and better insured patients
ithout providing better quality of care or outcomes (2–7).
or-profit hospitals have an incentive to maximize financial
argins from patient care. This strategy could occur by
electing younger patients with fewer comorbidities, per-
orming highly reimbursed procedures (e.g., coronary revas-
ularization), limiting use of expensive medical therapies, or
ecreasing length of stay (LOS).
Acute coronary syndrome (ACS) presents an ideal con-
ition for a comparison of medical treatment between
or-profit and nonprofit centers. First, American College of
ardiology/American Heart Association (ACC/AHA)
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October 9, 2007:1462–8 For-Profit Hospitals: Care and Outcomes for NSTEMIonsensus guidelines specify the proper evidenced-based
herapies and procedures for patients with ACS (8), and the
se of these clinical guidelines has been associated with
etter outcomes (9). Second, high transfer rates of patients
ith ACS make patient identification and selection straight-
orward. Third, treatment of ACS involves the use of expensive
echnologies, such as cardiac catheterization, percutaneous
oronary intervention (PCI), and coronary artery bypass graft
CABG) surgery. Acute coronary syndrome populations also
end to be heterogeneous, and the length of stay for these
atients would be expected to vary based on comorbid condi-
ions and characteristics of the treating center. Given these
actors, the differences in treatment and outcomes for
on–ST-segment elevation myocardial infarction (NSTEMI)
ay be different between for-profit and nonprofit hospitals
iven differences in financial strategy, resource allocation, and
ates of expensive procedures between the 2 hospital types.
Using data from the CRUSADE (Can Rapid risk strat-
fication of Unstable angina patients Suppress ADverse
utcomes with Early implementation of the ACC/AHA
uidelines) National Quality Improvement Initiative (10),
e examined the differences in case mix, medication and
rocedure use, and outcomes to assess potential differences
n care between the for-profit and nonprofit hospitals.
ethods
atients, inclusion criteria, and data collection. The
RUSADE Initiative is an observational registry that
dentifies patients with ischemic symptoms at rest within
4 h before presentation and high-risk ACS features,
ncluding ST-segment depression, transient ST-segment
levation, or positive cardiac markers (elevated troponin I or
and/or creatine kinase-MB greater than the upper limit of
ormal for the local laboratory assay). Data for patients
eeting these criteria are collected anonymously during the
ospitalization without informed consent and with institu-
ional review board approval of each participating institu-
ion. Data collected include baseline patient characteristics,
se of acute (within 24 h of hospital arrival) medications,
se and timing of invasive cardiac procedures, laboratory
esults, in-hospital clinical outcomes, and discharge thera-
ies and interventions. Contraindications to class IA or IB
herapeutic recommendations by the ACC/AHA guidelines
re recorded (11). The treating physician makes decisions
egarding the use of invasive procedures. Race and/or
thnicity classification are recorded by chart review at each
articipating site using provided definitions. Hospital profit
tatus in the CRUSADE Initiative was obtained using
merican Hospital Association registration data.
nalysis cohort. Between January 1, 2001 and December
1, 2005, 159,561 patients from 532 hospitals presented
ith NSTEMI. Unstable angina patients with ischemic
T-segment changes but without positive cardiac biomar-
ers (n  14,204) were excluded from our analysis. Among
he remaining NSTEMI patients (n  145,357), 11,658 p8.02%) were from 58 for-profit
ospitals, which compares with
he approximately 18% of for-
rofit hospitals registered with
he American Hospital Associa-
ion as of October 20, 2006 (12).
tatistical analysis. Baseline
atient characteristics and signs
nd symptoms at presentation
ere compared between for-
rofit and nonprofit centers. For
atients transferred out, baseline
atient characteristics and hospi-
al characteristics were analyzed
o characterize any differences
etween the 2 hospital types.
he chi-square test was used for
ategorical variables, and the
ilcoxon rank-sum test was used
or continuous variables. The
ean with standard deviation
nd percentages were reported to
escribe the distribution of con-
inuous and categorical variables,
espectively. Patients were excluded from the final analyses
f they had contraindications to evidence-based therapies
ithin 24 h of presentation or at discharge, or were
ransferred out. Patients who died were excluded from
nalysis of discharge medications. Patients transferred out
ere excluded from the analyses of in-hospital clinical
vents. Patients with contraindications to cardiac catheter-
zation, PCI, or CABG were excluded in the procedural
nalyses, and only hospitals with PCI or CABG services
ere included in procedural analyses. Any patients trans-
erred in or out were excluded from LOS analyses.
Multivariate regression analyses using generalized esti-
ating equations methods were performed to determine
hether for-profit was an independent factor that influ-
nced the use of medications within 24 h and at discharge,
n-hospital clinical events, in-hospital procedures, or LOS.
his model evaluated the differences between for-profit and
onprofit hospitals, adjusting for possible confounding fac-
ors. These variables included age, male gender, white race,
ody mass index, insurance status (health care maintenance
rganization/private, Medicare, Medicaid, self/none), fam-
ly history of coronary artery disease, hypertension, diabetes
ellitus, current/recent smoker (within 6 weeks of hospi-
alization), hypercholesterolemia, prior myocardial infarc-
ion, prior PCI, prior CABG, prior congestive heart failure
CHF), prior stroke, renal insufficiency (serum creatinine
2.0 mg/dl, calculated creatinine clearance30 ml/min, or
eed for renal dialysis), electrocardiographic findings at
dmission (ST-segment depression, transient ST-segment
levation, or both), signs of CHF, heart rate, systolic blood
Abbreviations
and Acronyms
ACC  American College of
Cardiology
ACS  acute coronary
syndrome
AHA  American Heart
Association
CABG  coronary artery
bypass graft
CHF  congestive heart
failure
HMO  health maintenance
organization
LOS  length of stay
NSTEMI  non–ST-segment
elevation myocardial
infarction
PCI  percutaneous
coronary intervention
STEMI  ST-segment
elevation myocardial
infarctionressure at admission, admitting physician (cardiologist vs.
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For-Profit Hospitals: Care and Outcomes for NSTEMI October 9, 2007:1462–8oncardiologist), number of hospital beds, region (North-
ast, South, West, Midwest), teaching status (academic vs.
onacademic hospital), and facility type (no services, cath-
terization lab only, PCI lab only but no surgery, and
urgery). Length of stay data were continuous and skewed to
he right, and were log transformed with the ratio of
djusted LOS reported.
A p value of0.05 was considered significant for all tests.
ll analyses were performed using SAS software (version
.2, SAS Institute, Inc., Cary, North Carolina).
esults
atient selection. The average age of the cohort was
7.3  14 years (Table 1). Women and white patients
omprised 39.3% and 80.6% of the study population,
espectively. The majority of patients (81.8%) were ini-
ially evaluated in an emergency room. Patients present-
ng with NSTEMI at for-profit hospitals were more
Patient Characteristics
Table 1 Patient Characteristics
Characteristics
Overall
(n  145,357
Age, yrs* 67.3  14.2
BMI, kg/m2* 28.7  6.8
Female gender 39.3
Race
White 80.6
Black 10.5
Asian 1.1
Hispanic 3.6
Other 2.6
Insurance
HMO/private 43.8
Medicare 42.2
Military/VAMC 0.73
Medicaid 6.09
Self/none 6.31
Family history of CAD 34.4
History of hypertension 69.3
Diabetes mellitus 33.0
Current/recent smoking† 27.2
Dyslipidemia 48.4
Prior MI 29.4
Prior PCI 20.2
Prior CABG 19.1
Any prior revascularization 33.3
Prior CHF 17.9
Prior stroke 10.5
Renal insufficiency‡ 13.9
Presentation features
ST-segment depression 30.3
Transient ST-segment elevation 6.0
Signs of CHF at presentation 23.8
Emergency department presentation 81.8
Data are presented as percentages, except as indicated. *Presented
hospitalization; ‡known serum creatinine 2.0 mg/dl, calculated creBMI  body mass index; CABG  coronary artery bypass graft; CAD  cor
maintenance organization; MImyocardial infarction; PCI percutaneous coikely to have health maintenance organization (HMO)/
rivate insurance, be nonwhite (black, Asian, Hispanic,
nd other), and have a slightly lower body mass index.
atients treated at for-profit hospitals had a higher
revalence of diabetes mellitus, CHF, hypertension, renal
nsufficiency, prior stroke, and prior revascularization
ith either CABG or PCI. Additionally, patients pre-
enting at for-profit hospitals were more likely to present
ith CHF and to have ST-segment depression, transient
T-segment elevation, or both at initial presentation.
ospital characteristics. Table 2 shows the characteristics
f the hospitals in the study cohort. In general, nonprofit
enters were more likely to be located in the Northeast and
idwest of the U.S. and were larger in size. For-profit
enters were more likely to be located in the Southern U.S.
nd less likely to have an academic affiliation.
atient transfers. Tables 3 and 4 compare patient and
ospital characteristics between nonprofit and for-profit
For-Profit
(n  11,658)
Nonprofit
(n  133,699) p Value
67.6  14.3 67.3  14.2 0.02
28.4  6.6 28.7  6.8 0.001
38.9 39.3 0.42
0.001
74.8 81.1
14.0 10.2
0.5 1.2
7.3 3.3
1.4 2.7
0.001
45.8 43.6
40.5 42.3
0.40 0.76
6.45 6.06
6.07 6.33
34.1 34.5 0.76
70.9 69.2 0.001
33.8 32.9 0.01
26.9 27.3 0.61
48.4 48.4 0.49
27.9 29.6 0.002
20.1 20.3 0.85
19.7 19.0 0.03
32.9 32.2 0.03
19.5 17.8 0.001
11.2 10.5 0.01
15.4 13.7 0.001
34.9 29.9 0.001
9.3 5.7
24.7 23.8 0.01
82.3 81.7 0.001
n  SD; †recent smoking defined as within the last 6 weeks before
clearance 30 ml/min, or need for renal dialysis.)
as mea
atinineonary artery disease; CHF  congestive heart failure; HMO  health
ronary intervention; VAMC Veterans Administration Medical Center.
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October 9, 2007:1462–8 For-Profit Hospitals: Care and Outcomes for NSTEMIenters that were transferred to other facilities. Of the total
atients initially evaluated, 10.3% of patients at for-profit
ospitals and 12.2% of patients at nonprofit hospitals were
ransferred out. Patients transferred out from for-profit
ospitals were older and more likely to have CHF, hyper-
ension, renal insufficiency, signs of CHF at admission, and
lectrocardiogram changes, but less likely to have a family
istory of CAD and prior PCI. Nonprofit hospitals that
ransferred patients were more likely not to have cardiac
atheterization or surgical services, whereas for-profit hos-
itals were more likely to have PCI services without surgical
ervices.
herapies, event rates, and outcomes. Multivariate anal-
ses for differences among medical therapies, hospital event
ates, and outcomes are shown in Tables 5 to 7. For-profit
ospitals were less likely to discharge patients with beta-
locker therapy; otherwise, the use of evidence-based ther-
pies was not statistically different between the 2 hospital
ypes. No differences in the rates of diagnostic catheteriza-
ion, PCI, or CABG were found. In-hospital incidences of
HF, cardiogenic shock, stroke, death, bleeding complica-
ions, or transfusion requirements were also similar between
he 2 hospital types. Length of stay was also similar between
he 2 hospital types.
iscussion
his analysis demonstrates that for-profit centers did not
electively care for patients who were younger or healthier
han patients treated at nonprofit hospitals. There was no
ignificant difference in the use of evidence-based therapies,
OS, in-hospital outcomes, and rates of revascularization
or patients with NSTEMI between the 2 hospital types.
Prior studies have examined the impact of hospital
wnership structure on procedure rates, quality measures,
nd outcomes in a variety of patient populations. For-profit
enters have a different financial resource allocation than
Hospital Characteristics
Table 2 Hospital Characteristics
Characteristics
Overall
(n  145,357)
Region
West 12.2
Northeast 22.2
Midwest 32.8
South 32.8
Type of hospital
No services 5.64
Cath lab only 9.1
PCI, no surgery 6.1
PCI, with surgery 79.2
Teaching hospital*
Academic 28.3
Total hospital beds† 404  219
Data are presented as percentages except as indicated. *Membership
PCI  percutaneous coronary intervention.onprofit hospitals (13–15), and previous studies have oemonstrated higher rates of expensive technology use and
ncreased mortality when compared with nonprofit facilities
4,5,14,16,17). Most of these studies, however, have exam-
ned broad patient populations where care varies based on
he admitting diagnosis, thus confounding identifiable
ources of differences in care and outcomes between the 2
ospital types. Therefore, it has been difficult to ascertain
hether differences in the care and outcomes seen between
hese hospital types are real or reflect patient diagnosis or
llness severity. Patients presenting with ACS are an ideal
tudy cohort to examine these differences. The clinical
iagnosis relies on common laboratory and diagnostic tests,
nd treatment is based on widely disseminated guidelines
hat have been shown to positively influence outcomes (9).
herefore, any differences in treatment or outcomes in an
CS population would reflect fundamental differences in
esource allocation, processes, or preferences for particular
reatments or patient characteristics.
In the analysis of an ACS population, Sloan et al. (7)
xamined care processes and outcomes from a Medicare
opulation presenting with ACS. Similar to Sloan et al. (7),
e found no evidence that for-profit hospitals care for
ounger or healthier patients. However, we examined a
roader ACS population in terms of age and reimbursement
nd were able to identify that treatment patterns at for-
rofit centers were not influenced by the patient’s insurance
tatus. Unlike their findings, we could not find any differ-
nces in the use of expensive procedures and discharge use
f aspirin and angiotensin-converting enzyme inhibitors
etween the 2 hospital types. These differences could be the
esult of the fact that their analysis examined patients with
T-segment elevation myocardial infarction (STEMI) and
STEMI exclusively in a Medicare population. However,
iven that most of the guidelines for care (beyond acute
eperfusion) are similar for STEMI and NSTEMI, we
ould not have expected differences in the utilization rates
r-Profit
11,658)
Nonprofit
(n  133,699) p Value
3.5 12.1 0.001
4.3 23.7
6.6 35.1
5.6 29.1
0.03 6.12 0.001
0.7 9.0
9.8 5.8
9.4 79.1
0.7 29.8 0.001
 112 414  223 0.001
ncil of Teaching Hospitals; †presented as mean  SD.Fo
(n 
1
7
1
7
1
298f evidence-based therapies between the 2 analyses. Fur-
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Table 3 Characteristics of Patients Transferred Out
Characteristics
Overall
(n  17,561)
For-Profit
(n  1,200)
Nonprofit
(n  16,361) p Value
Age, yrs* 65.9  13.2 67.8  13.5 65.7  13.2 0.001
BMI, kg/m2* 29.0  6.6 28.9  7.0 29.1  6.6 0.11
Female gender 36.8 36.5 36.8 0.87
Race 0.003
White 82.7 83.3 82.7
Black 7.6 9.5 7.4
Asian 0.95 0.58 0.97
Hispanic 4.4 3.7 4.5
Other 2.8 1.7 2.9
Insurance 0.003
HMO/private 46.4 43.9 46.6
Medicare 39.7 44.0 39.4
Military/VAMC 0.69 0.33 0.72
Medicaid 5.5 5.6 5.5
Self/none 6.6 4.9 6.8
Family history of CAD 38.3 33.0 38.6 0.001
History of hypertension 66.8 69.9 66.5 0.003
Diabetes mellitus 33.2 35.0 33.1 0.06
Current/recent smoking† 28.3 25.2 28.5 0.03
Dyslipidemia 47.6 48.1 47.5 0.52
Prior MI 26.6 26.0 26.6 0.98
Prior PCI 18.7 15.8 18.9 0.02
Prior CABG 15.7 16.8 15.7 0.19
Any prior revascularization 28.7 28.1 28.7 0.95
Prior CHF 13.3 16.8 13.1 0.001
Prior stroke 8.7 9.5 8.7 0.20
Renal insufficiency‡ 9.8 12.0 9.7 0.004
Presentation features
ST-segment depression 32.7 44.8 31.8 0.001
Transient ST-segment elevation 21.7 12.7 5.1
Signs of CHF at presentation 23.8 25.9 21.4 0.001
Emergency department presentation 92.2 87.2 92.6 0.05
Data are presented as percentages except as indicated. *Presented as mean  SD; †recent smoking defined as within the last weeks before
hospitalization; ‡known serum creatinine 2.0 mg/dl, calculated creatinine clearance 30 ml/min, or need for renal dialysis.
Abbreviations as in Table 1.Hospital Characteristics for Patients Transferred Out
Table 4 Hospital Characteristics for Patients Transferred Out
Characteristics
Overall
(n  17,561)
For-Profit
(n  1,200)
Nonprofit
(n  16,361) p Value
Region
West 11.1 3.5 11.7 0.001
Northeast 31.2 0.4 33.5
Midwest 12.5 1.75 13.3
South 45.2 94.3 41.6
Type of hospital
No services 24.6 0.08 26.4 0.001
Cath lab only 35.5 32.7 35.7
PCI, no surgery 21.8 50.3 19.8
PCI, with surgery 18.0 17.0 18.1
Teaching hospital*
Academic 7.1 3.3 7.3 0.001
Total hospital beds† 255  158 225  85 258  161 0.01Data are presented as percentages except as indicated. *Membership in Council of Teaching Hospitals; †presented as mean  SD.
PCI  percutaneous coronary intervention.
t
M
s
e
o
a
h
h
r
c
fi
a
h
M
s
n
p
A
s
w
d
a
d
B
p
d
p
p
r
f
r
t
P
t
p
r
S
c
F
o
i
m
n
t
n
h
t
N
o
t
p
p
h
i
l
ar-weig
1467JACC Vol. 50, No. 15, 2007 Shah et al.
October 9, 2007:1462–8 For-Profit Hospitals: Care and Outcomes for NSTEMIhermore, Sloan et al. (7) restricted their analysis to a
edicare population, yet our conclusions regarding the
imilarity in care and outcomes by center type remain robust
ven when our analysis was limited to those age 65 years or
lder (data not presented). Additionally, it remains unclear
s to whether these study differences reflect the fact that we
ad access to more contemporary clinical data.
Previous studies have shown that for-profit organizations
ave similar or increased usage rates of procedures with high
eimbursement potential including, but not restricted to,
ardiac catheterization, CABG, and PCI (7,18). We did not
nd any difference in the rates of these procedures in our
nalysis, which is contrary to the expectation that for-profit
ospitals may limit the use of these procedures, especially to
edicare beneficiaries and the under- or uninsured, as a
trategy to enhance their profitability. Similarly, we found
o evidence that for-profit centers were less likely to use
harmacologic treatments recommended by the ACC/
HA guidelines for patients with NSTEMI. The only
ignificant difference we found between the 2 hospital types
as the lower adjusted rate of beta-blockers given at
ischarge at for-profit hospitals. The findings may represent
type I statistical error, given that there were no significant
ifferences among the other similar therapies measured.
eta-blocker therapy is relatively inexpensive and, unlike
rocedures, has no large financial impact that would drive a
ifference in its use between the 2 hospital types.
Our analysis is the first to compare the characteristics of
atients transferred and transferring hospitals. Both non-
Guideline-Based Medication and Invasive Proced
Table 5 Guideline-Based Medication and Inv
Outcome
For-Profit
(n  11,658)
Acute aspirin 93.2
Acute beta-blocker 81.4
Acute clopidogrel 49.1
Acute heparin (UFH or LMWH) 86.3
Acute GP IIb/IIIa 41.3
Catheterization (overall) 72.3
Catheterization within 48 h of arrival 51.3
PCI 46.5
PCI within 48 h of arrival 35.3
CABG 13.2
Data are presented as percentages. The odds ratios (ORs) compare fo
CI  confidence interval; GP  glycoprotein; LMWH  low-molecul
Table 1.
Guideline-Based Discharge Therapies
Table 6 Guideline-Based Discharge Therapie
Discharge Therapies
For-Profit
(n  11,658)
Aspirin 91.9
Beta-blocker 84.6
ACE inhibitor 59.9
Clopidogrel 64.0
Lipid-lowering agent 81.5Data are presented as percentages. The ORs compare for-profit with nonprofi
ACE  angiotensin-converting enzyme; other abbreviations as in Table 5.rofit and for-profit hospitals had similar rates of transfer-
ing patients. The characteristics of patients transferred out
rom for-profit and nonprofit hospitals were similar in
egards to comorbidities and features at presentation as
hose not transferred. However, for-profit hospitals with
CI services, but without surgical back-up, were more likely
o transfer patients to other hospitals that could presumably
rovide the more advanced care that these patients may
equire.
tudy limitations. There are several issues that should be
onsidered in the interpretation of the results of this study.
irst, we did not include measures of physician ownership in
ur analysis of for-profit hospitals, given the difficulty in
dentifying this data. We would expect that these hospitals
ight have increased procedure use compared with
onphysician-owned hospitals and to be more selective of
he patients they treat. Also, for patients transferred out, we
either have data for the reason for transfer nor the type of
ospital to which they were transferred limiting our ability
o make further conclusions on these observations.
In our analysis, we limited our scope to a single diagnosis,
STEMI. There could be other conditions that influence
r affect this diagnosis that may not have been captured by
he data. Additionally, the CRUSADE Initiative does not
rovide information for long-term care or outcomes for
atients, effectively limiting any conclusions between the 2
ospital types in this regard. However, given the similarities
n acute care and outcomes, long-term differences maybe
ess likely.
se
Procedure Use
Nonprofit
(n  133,699)
Adjusted OR
(95% CI) p Value
93.8 0.91 (0.70–1.17) 0.46
85.3 0.80 (0.62–1.03) 0.09
46.7 1.17 (0.95–1.45) 0.15
86.7 0.90 (0.70–1.16) 0.43
43.2 0.89 (0.71–1.10) 0.29
75.9 0.93 (0.63–1.37) 0.71
54.8 1.13 (0.88–1.46) 0.35
47.1 1.14 (0.95–1.38) 0.17
35.1 1.16 (0.97–1.39) 0.10
13.6 0.88 (0.71–1.10) 0.27
with nonprofit hospitals.
ht heparin; UFH  unfractionated heparin; other abbreviations as in
profit
33,699)
Adjusted OR
(95% CI) p Value
2.3 0.97 (0.75–1.26) 0.84
8.5 0.76 (0.59–0.99) 0.04
3.7 0.86 (0.70–1.04) 0.12
3.3 1.14 (0.94–1.39) 0.18
4.4 0.91 (0.69–1.19) 0.50ure U
asive
r-profits
Non
(n  1
9
8
6
6
8t hospitals.
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For-Profit Hospitals: Care and Outcomes for NSTEMI October 9, 2007:1462–8Hospital participation in the CRUSADE Initiative is
oluntary, and hospitals in the program most likely self-
elect for those most interested in improving quality of care.
oth the care and outcomes are self-reported, yet these data
ave been audited and validated (9). Furthermore, these
ata are not linked to external public or financial incentives;
hus, sites have less motivation for false reporting.
onclusions
e found that adjusted in-hospital outcomes for NSTEMI
atients at for-profit hospitals were similar to nonprofit hos-
itals. Despite organizational differences that may exist in fiscal
trategy and resource allocations, no differences were found in
uality measures, in-hospital outcomes, or procedure utiliza-
ion. We also could not find any care-shifting as these hospitals
reated patients with more comorbidities, similar insurance
tatus, and similar demographics as nonprofit hospitals. How-
ver, further studies are needed to evaluate whether patient
haracteristics, treatment patterns, and clinical outcomes differ
t specialty cardiac hospitals and physician-owned hospitals.
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